Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

52
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
52

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A real-world decision tree model based on ¹⁸F-FDG PET/CT Z scores and Mini-Mental State Examination for differentiating mild cognitive impairment from clinically diagnosed Alzheimer disease.

Annals of nuclear medicine·2026
Same author

Urinary Dysfunction in Myasthenic Syndromes: A Scoping Review of Clinical Features and Treatment-Related Associations.

Muscle & nerve·2026
Same author

Eyes closed single-leg stance test detects subtle sensorimotor decline in early multiple sclerosis.

Scientific reports·2026
Same author

Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia.

Cell reports. Medicine·2026
Same author

Histopathological Analysis of Thrombi in Acute Ischemic Stroke: An Exploratory Study of Thrombus Composition and CD34-Positive Endothelial Cells.

Diagnostics (Basel, Switzerland)·2026
Same author

Hyperintense acute reperfusion marker (HARM) and thrombus analysis in acute ischemic stroke.

Frontiers in neurology·2026

Related Experiment Video

Updated: May 5, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K

Combined Central and Peripheral Demyelination: Two Case Reports.

Buse Gül Belen1, Nazlı Gamze Bülbül1, Sibel Karsidag1

  • 1Department of Neurology, SBU Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey.

European Neurology
|February 7, 2024
PubMed
Summary

Combined central and peripheral demyelination (CCPD) is a rare neurological disorder. Investigating anti-neurofascin antibodies aids in diagnosing CCPD, which affects both the central and peripheral nervous systems.

Keywords:
Anti-NF 155Anti-NF 186Case reportCombined central and peripheral demyelinationNeurofascin

More Related Videos

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.8K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.2K

Related Experiment Videos

Last Updated: May 5, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K
A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.8K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.2K

Area of Science:

  • Neurology
  • Neuroimmunology
  • Demyelinating Diseases

Background:

  • Combined central and peripheral demyelination (CCPD) is a rare condition affecting both the central nervous system (CNS) and peripheral nervous system (PNS).
  • CCPD presents with heterogeneous clinical manifestations and lacks definitive diagnostic criteria.
  • Demyelinating lesions in CCPD can occur in various CNS and PNS locations.

Observation:

  • Neuroimaging (MRI) reveals demyelinating lesions in the brain, spinal cord, and optic nerves.
  • Electromyography (EMG) shows characteristic findings such as reduced nerve conduction velocities and altered potentials.
  • Anti-neurofascin (anti-NF) antibodies, targeting specific neurofascin polypeptides, can be detected in CCPD patients.

Findings:

  • This study presents three CCPD cases diagnosed using clinical, neuroimaging, EMG, and anti-NF antibody data.
  • The findings highlight the utility of anti-NF antibody testing in CCPD diagnosis.
  • Alternative splicing of neurofascin (NF) produces multiple polypeptides, relevant for antibody investigations.

Implications:

  • Identifying anti-NF antibodies is crucial for understanding the etiology of CCPD.
  • Accurate diagnosis of CCPD aids in appropriate patient management and treatment strategies.
  • Further research into anti-NF antibodies may refine diagnostic criteria for CCPD.